EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
M FilippiJ S Wolinsky

Abstract

Magnetic resonance (MR)-based techniques are widely used for the assessment of patients with suspected and definite multiple sclerosis (MS). However, despite the publication of several position papers, which attempted to define the utility of MR techniques in the management of MS, their application in everyday clinical practice is still suboptimal. This is probably related, not only, to the fact that the majority of published guidelines focused on the optimization of MR technology in clinical trials, but also to the continuing development of modern, quantitative MR-based techniques, that have not as yet entered the clinical arena. The present report summarizes the conclusions of the 'EFNS Expert Panel of Neuroimaging of MS' on the application of conventional and non-conventional MR techniques to the clinical management of patients with MS. These guidelines are intended to assist in the use of conventional MRI for the diagnosis and longitudinal monitoring of patients with MS. In addition, they should provide a foundation for the development of more widespread but rational clinical applications of non-conventional MR-based techniques in studies of MS patients.

References

Mar 10, 1990·BMJ : British Medical Journal·A J ThompsonW I McDonald
Feb 1, 1988·Neurology·D H MillerW I McDonald
Aug 1, 1988·Brain : a Journal of Neurology·D H MillerW I McDonald
Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
Jan 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·M FilippiG Comi
May 1, 1993·Neurology·H OffenbacherH Lechner
Jan 1, 1995·Duodecim; lääketieteellinen aikakauskirja·M PaneliusJ Ruutiainen
Jul 1, 1996·Journal of Magnetic Resonance Imaging : JMRI·C GasperiniW I McDonald
Dec 1, 1996·Brain : a Journal of Neurology·N A LosseffA J Thompson
Mar 1, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·T KoudriavtsevaC Pozzilli
Apr 1, 1997·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·M FilippiG Comi
Mar 7, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·P SarchielliV Gallai
Apr 29, 1998·Brain : a Journal of Neurology·D H MillerH F McFarland
Apr 29, 1998·Brain : a Journal of Neurology·J I O'RiordanD H Miller
Jul 30, 1999·Journal of Neuroimmunology·J H Simon

❮ Previous
Next ❯

Citations

Aug 17, 2006·Der Nervenarzt·H WiendlH-P Hartung
Dec 1, 2006·Der Nervenarzt·Peter Rieckmann, Peter Rieckmann
Dec 18, 2007·Journal of Neurology·Jui PerumalOmar Khan
Nov 14, 2008·Journal of Neurology·UNKNOWN Multiple Sclerosis Therapy Consensus Group (MSTCG)R Hohlfeld
Oct 1, 2010·Radiological Physics and Technology·Taiki MagomeYukunori Korogi
Dec 22, 1999·Neuropsychologia·M Scarrabelotti, M Carroll
May 30, 2008·European Radiology·Bastiaan MoraalFrederik Barkhof
Sep 26, 2012·Journal of the Neurological Sciences·Luca ProsperiniCarlo Pozzilli
Mar 9, 2012·Revue neurologique·H ZéphirUNKNOWN GRESEP (Groupe de Reflexion sur la Sclerose en Plaques; Multiple Sclerosis Think Tank)
Apr 27, 2010·Clinical Neurology and Neurosurgery·Mohammad Ali Sahraian, Arman Eshaghi
Mar 2, 2010·Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society·Daisuke YamamotoYukunori Korogi
Aug 28, 2009·Journal of the Neurological Sciences·Franz FazekasSiegrid Fuchs
Mar 24, 2009·Journal of Magnetic Resonance Imaging : JMRI·M M VellingaH Vrenken
Apr 12, 2007·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Franz FazekasMassimo Filippi
Oct 17, 2016·Neurology and Therapy·Sheena L DupuyRohit Bakshi
Aug 11, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Luca ProsperiniClaudio Gasperini
Sep 4, 2013·Multiple Sclerosis : Clinical and Laboratory Research·Luca ProsperiniCarlo Pozzilli
Dec 14, 2011·Therapeutic Advances in Neurological Disorders·Adriana CarráDarwin Vizcarra-Escobar
Mar 7, 2017·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Brian C HealyRohit Bakshi
Jan 1, 2011·The Neurohospitalist·Vanja C Douglas, S Andrew Josephson
Nov 8, 2007·Multiple Sclerosis : Clinical and Laboratory Research·S Strasser-FuchsF Fazekas
Jul 9, 2008·Current Opinion in Neurology·Carolina CiumasPhilippe Ryvlin
Dec 14, 2017·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Dominik S MeierHoward L Weiner
Mar 15, 2015·Expert Review of Neurotherapeutics·Mark S Freedman, Mohammad Abdoli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.